Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
申请人:NEURIM PHARMACEUTICALS (1991) LIMITED
公开号:EP2664615A1
公开(公告)日:2013-11-20
This invention is directed to substituted aryl compounds, which are linked to a substituted indole moiety by various linkers, and the kynurenine/kynuramine-like metabolites of these agents, their preparation and pharmaceutical compositions containing these compounds. This invention further is directed to the pharmaceutical use of the compounds for inhibiting GSK3β kinase and/or modulating N-methyl-D-aspartate (NMDA) channel activities for the treatment of neurodegenerative and other disorders.